Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_provenance.
- NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_assertion description "[These data support a role for PI3K-AKT pathway activation in kidney tumor formation caused by loss of BHD and suggest that inhibitors of both mTORC1 and mTORC2 may be effective as potential therapeutic agents for BHD-associated kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_provenance.
- NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_assertion evidence source_evidence_literature NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_provenance.
- NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_assertion SIO_000772 19850877 NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_provenance.
- NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_assertion wasDerivedFrom befree-2016 NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_provenance.
- NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_assertion wasGeneratedBy ECO_0000203 NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_provenance.
- befree-2016 importedOn "2016-02-19" NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_provenance.